Namely, the peptide reduced the expression of many genes (e.g., P2rx6, Gabra3, Grik4, Oprl1, Glra2, Crhr1, Hrh1, Chrm5, Grik1) related to the neurosignaling system and whose expression was not significantly changed by ischemia itself. This evidence concerns the gene CHRM5 and ischemia.